FDA Inspection 1322648 — Quagen Pharmaceuticals LLC
The FDA completed an inspection of Quagen Pharmaceuticals LLC on May 19, 2026 in West Caldwell, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 19, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- West Caldwell, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)